ER
Eduardo Ricardo Dos Santos Montanha
About Eduardo Ricardo Dos Santos Montanha
Data last updated:
Eduardo Ricardo Dos Santos Montanha is an Additional Director at Fresenius Kabi Oncology Limited (since 2025). The companies operate in Pharma. Fresenius Kabi Oncology Limited reported revenue of ₹848 Cr (FY 2025). Earlier, Eduardo Ricardo Dos Santos Montanha was a Director at Zydus Takeda Healthcare Private Limited (2018–2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Fresenius Kabi Oncology Limited U24231DL2003PLC119441 | Additional Director | 15 Sep 2025 | 2003 | ₹848 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Zydus Takeda Healthcare Private Limited U24231MH1999PTC119171 | Director | 27 Jun 2018 | 1999 | ₹362 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Eduardo Ricardo Dos Santos Montanha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arvind Kumar Sharma | 08144338 | Fresenius Kabi Oncology Limited | Managing Director |
| Heike Susanne Van Dawen | 10645045 | Fresenius Kabi Oncology Limited | Director |
| Maximilian Alexander Bohmer | 10279854 | Fresenius Kabi Oncology Limited | Director |
| Nikhil Kulshreshtha | 07178027 | Fresenius Kabi Oncology Limited | Nodal Officer |
| Nikhil Kulshreshtha | Fresenius Kabi Oncology Limited | Company Secretary | |
| Rahul Sharma | Fresenius Kabi Oncology Limited | Cfo |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Eduardo Ricardo Dos Santos Montanha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eduardo Ricardo Dos Santos Montanha
Eduardo Ricardo Dos Santos Montanha currently holds 1 directorship: Fresenius Kabi Oncology Limited (Additional Director, since 15 Sep 2025, revenue ₹848 Cr (FY 2025)).
Eduardo Ricardo Dos Santos Montanha was first appointed on 27 Jun 2018 as Director at Zydus Takeda Healthcare Private Limited. The most recent appointment on record is 15 Sep 2025 at Fresenius Kabi Oncology Limited.
Eduardo Ricardo Dos Santos Montanha held 1 earlier board appointment: Zydus Takeda Healthcare Private Limited (Director, 27 Jun 2018 to 14 Nov 2023).
The current boards of Eduardo Ricardo Dos Santos Montanha's companies include Arvind Kumar Sharma (Fresenius Kabi Oncology Limited), Heike Susanne Van Dawen (Fresenius Kabi Oncology Limited), Maximilian Alexander Bohmer (Fresenius Kabi Oncology Limited), Nikhil Kulshreshtha (Fresenius Kabi Oncology Limited), Nikhil Kulshreshtha (Fresenius Kabi Oncology Limited), Rahul Sharma (Fresenius Kabi Oncology Limited).